This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignees: Jiangsu Nhwa Pharmaceutical Co., Ltd, Shujing Biopharma Co., Ltd. Active years: 2026.
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2026
Title: Zhijing Hu: Innovator in Neuropsychiatric Medicaments
Introduction
Zhijing Hu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating neuropsychiatric diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Zhijing Hu holds a patent for a "Heterocyclic substituted fused γ-carboline derivative, preparation method therefor, intermediate thereof and use thereof." This invention relates to a unique compound structure that can be utilized in the preparation of medicaments for treating neuropsychiatric diseases. The compound is represented by a specific formula, indicating its potential therapeutic applications.
Career Highlights
Throughout his career, Zhijing Hu has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Jiangsu Nhwa Pharmaceutical Co., Ltd and Shujing Biopharma Co., Ltd. His experience in these organizations has allowed him to collaborate with other talented professionals in the field.
Collaborations
Zhijing Hu has worked alongside esteemed colleagues such as Jun Qin and Bingcheng Zhou. Their collaborative efforts have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Zhijing Hu's innovative contributions to the field of neuropsychiatric medicaments highlight his role as a significant inventor. His patent and collaborations reflect his commitment to improving healthcare through scientific advancements.